Attached files

file filename
10-Q - PharMerica CORPform10q.htm
EX-32.2 - PharMerica CORPex32_2.htm
EX-31.1 - PharMerica CORPex31_1.htm
EX-31.2 - PharMerica CORPex31_2.htm
EX-10.30 - DAVID FROESEL'S EMPLOYMENT AGREEMENT - PharMerica CORPex10_30.htm
EXCEL - IDEA: XBRL DOCUMENT - PharMerica CORPFinancial_Report.xls
EX-10.31 - JAMES GLYNN EMPLOYMENT AGREEMENT - PharMerica CORPex10_31.htm

Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of PharMerica Corporation (the “Corporation”) on Form 10-Q for the quarter ended June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory S. Weishar, Chief Executive Officer and Director of the Corporation, certify, pursuant to18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
 
/S/ GREGORY W. WEISHAR
 
Gregory S. Weishar
Chief Executive Officer and Director
August 5, 2014